CYCLOCORT
LOE ApproachingNDATOPICALCREAM
Approved
Oct 1979
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 6h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CYCLOCORT is a topical cream formulation containing a small-molecule corticosteroid approved in 1979 for dermatological use. The product is a classical anti-inflammatory agent applied directly to skin, with mechanism of action typical of corticosteroid receptor agonism. It treats various inflammatory and pruritic skin conditions.
LOE Approaching
As a product approaching loss of exclusivity with moderate competitive pressure (30 score), team sizes and investment are likely contracting or stabilizing in a mature, commoditized market.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Zero linked job openings reflect the mature, declining phase of this product lifecycle; career opportunities are extremely limited. Roles on CYCLOCORT would focus on defending market share and managing generic transition rather than growth initiatives.
Brand ManagerMarket Access Manager
Worked on CYCLOCORT at Astellas? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.